BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20018718)

  • 1. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.
    Berdasco M; Ropero S; Setien F; Fraga MF; Lapunzina P; Losson R; Alaminos M; Cheung NK; Rahman N; Esteller M
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21830-5. PubMed ID: 20018718
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.
    Douglas J; Hanks S; Temple IK; Davies S; Murray A; Upadhyaya M; Tomkins S; Hughes HE; Cole TR; Rahman N
    Am J Hum Genet; 2003 Jan; 72(1):132-43. PubMed ID: 12464997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
    Lucio-Eterovic AK; Singh MM; Gardner JE; Veerappan CS; Rice JC; Carpenter PB
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16952-7. PubMed ID: 20837538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
    Watanabe H; Higashimoto K; Miyake N; Morita S; Horii T; Kimura M; Suzuki T; Maeda T; Hidaka H; Aoki S; Yatsuki H; Okamoto N; Uemura T; Hatada I; Matsumoto N; Soejima H
    FASEB J; 2020 Jan; 34(1):960-973. PubMed ID: 31914674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSD1 mutations deregulate transcription and DNA methylation of bivalent developmental genes in Sotos syndrome.
    Brennan K; Zheng H; Fahrner JA; Shin JH; Gentles AJ; Schaefer B; Sunwoo JB; Bernstein JA; Gevaert O
    Hum Mol Genet; 2022 Jul; 31(13):2164-2184. PubMed ID: 35094088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the NSD1 gene in a group of 59 patients with congenital overgrowth.
    Cecconi M; Forzano F; Milani D; Cavani S; Baldo C; Selicorni A; Pantaleoni C; Silengo M; Ferrero GB; Scarano G; Della Monica M; Fischetto R; Grammatico P; Majore S; Zampino G; Memo L; Cordisco EL; Neri G; Pierluigi M; Bricarelli FD; Grasso M; Faravelli F
    Am J Med Genet A; 2005 Apr; 134(3):247-53. PubMed ID: 15742365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1.
    Martin-Herranz DE; Aref-Eshghi E; Bonder MJ; Stubbs TM; Choufani S; Weksberg R; Stegle O; Sadikovic B; Reik W; Thornton JM
    Genome Biol; 2019 Aug; 20(1):146. PubMed ID: 31409373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of alternative transcripts of NSD1 gene in Sotos Syndrome patients and healthy subjects.
    Conteduca G; Testa B; Baldo C; Arado A; Malacarne M; Candiano G; Garbarino A; Coviello DA; Cantoni C
    Gene; 2023 Jan; 851():146970. PubMed ID: 36261088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in SETD2 cause a novel overgrowth condition.
    Luscan A; Laurendeau I; Malan V; Francannet C; Odent S; Giuliano F; Lacombe D; Touraine R; Vidaud M; Pasmant E; Cormier-Daire V
    J Med Genet; 2014 Aug; 51(8):512-7. PubMed ID: 24852293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.
    Tatton-Brown K; Douglas J; Coleman K; Baujat G; Cole TR; Das S; Horn D; Hughes HE; Temple IK; Faravelli F; Waggoner D; Turkmen S; Cormier-Daire V; Irrthum A; Rahman N;
    Am J Hum Genet; 2005 Aug; 77(2):193-204. PubMed ID: 15942875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSD1 analysis for Sotos syndrome: insights and perspectives from the clinical laboratory.
    Waggoner DJ; Raca G; Welch K; Dempsey M; Anderes E; Ostrovnaya I; Alkhateeb A; Kamimura J; Matsumoto N; Schaeffer GB; Martin CL; Das S
    Genet Med; 2005 Oct; 7(8):524-33. PubMed ID: 16247291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of NSD1 mutations in Sotos and Weaver syndromes.
    Rio M; Clech L; Amiel J; Faivre L; Lyonnet S; Le Merrer M; Odent S; Lacombe D; Edery P; Brauner R; Raoul O; Gosset P; Prieur M; Vekemans M; Munnich A; Colleaux L; Cormier-Daire V
    J Med Genet; 2003 Jun; 40(6):436-40. PubMed ID: 12807965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotos syndrome.
    Tatton-Brown K; Rahman N
    Eur J Hum Genet; 2007 Mar; 15(3):264-71. PubMed ID: 16969376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1.
    Sun Z; Lin Y; Islam MT; Koche R; Hedehus L; Liu D; Huang C; Vierbuchen T; Sawyers CL; Helin K
    Mol Cell; 2023 Jul; 83(14):2398-2416.e12. PubMed ID: 37402365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations.
    Grand K; Gonzalez-Gandolfi C; Ackermann AM; Aljeaid D; Bedoukian E; Bird LM; De Leon DD; Diaz J; Hopkin RJ; Kadakia SP; Keena B; Klein KO; Krantz I; Leon E; Lord K; McDougall C; Medne L; Skraban CM; Stanley CA; Tarpinian J; Zackai E; Deardorff MA; Kalish JM
    Am J Med Genet A; 2019 Apr; 179(4):542-551. PubMed ID: 30719864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the NSD1 promoter region in patients with a Sotos syndrome phenotype.
    Visser R; Hasegawa T; Niikawa N; Matsumoto N
    J Hum Genet; 2006; 51(1):15-20. PubMed ID: 16252063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
    Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
    Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoparathyroidism in a 3-year-old Korean boy with Sotos syndrome and a novel mutation in NSD1.
    Wejaphikul K; Cho SY; Huh R; Kwun Y; Lee J; Ki CS; Jin DK
    Ann Clin Lab Sci; 2015; 45(2):215-8. PubMed ID: 25887879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating cortical features of Sotos syndrome using mice heterozygous for Nsd1.
    Oishi S; Zalucki O; Vega MS; Harkins D; Harvey TJ; Kasherman M; Davila RA; Hale L; White M; Piltz S; Thomas P; Burne THJ; Harris L; Piper M
    Genes Brain Behav; 2020 Apr; 19(4):e12637. PubMed ID: 31909872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.